Physician profile
Michael W Gen
NPI 1487623906
$206,864.16
in general payments reported to CMS, 2019-2025
65 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $23K · 2021: $13K · 2022: $24K · 2023: $46K · 2024: $40K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $14K · Food and Beverage: $11K · Education: $41.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,341.00 |
| Travel and Lodging | $14,453.77 |
| Food and Beverage | $10,763.42 |
| Education | $41.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $140,771.34 | 2019-2025 | Repatha, Repatha |
| Lundbeck LLC | $29,759.90 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $8,399.05 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $6,524.67 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Medtronic, INC. | $2,414.21 | 2021-2025 | Symplicity G3, Micra, Onyx Frontier |
| Abbott Laboratories | $2,379.62 | 2019-2025 | Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Philips North America LLC | $1,618.99 | 2019-2025 | Azurion 5 M20, (5153) Azurion 5 M20 Gc, (Cq0) Azurion 5 M20 Gc |
| Edwards Lifesciences Corporation | $1,597.34 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,136.21 | 2019-2024 | Impella |
| Biotronik INC. | $864.83 | 2019-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Selectra |
| Boston Scientific Corporation | $839.08 | 2019-2025 | Watchman Flx, Jetstream Sc, Watchman |
| Pfizer INC. | $814.86 | 2019-2025 | |
| Amarin Pharma, INC. | $745.83 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $667.26 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $586.64 | 2021-2022 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $576.75 | 2020-2021 | |
| Cvrx, INC. | $557.82 | 2023-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $551.29 | 2019-2020 | |
| Akcea Therapeutics, INC. | $519.97 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $510.79 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $453.75 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $425.13 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $360.10 | 2021-2025 | Verquvo, Capvaxive |
| Alnylam Pharmaceuticals INC. | $320.07 | 2022-2025 | Onpattro, Amvuttra |
| Shockwave Medical, INC | $313.32 | 2020-2022 | |
| Teleflex LLC | $310.85 | 2023-2024 | Supercross, Manta, Guideliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $307.42 | 2021-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $205.39 | 2019-2022 | |
| Esperion Therapeutics, INC. | $193.46 | 2020-2025 | Nexletol |
| Scpharmaceuticals INC. | $180.24 | 2024-2025 | |
| Novo Nordisk INC | $165.75 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $146.30 | 2023-2025 | Camzyos, Eliquis |
| Lilly USA, LLC | $136.93 | 2020-2025 | Zepbound, Mounjaro |
| Ge Healthcare | $119.27 | 2024 | |
| Livanova USA, INC. | $109.84 | 2023 | Lifesparc |
| Venclose INC. | $98.50 | 2020 | |
| Cordis US Corp. | $93.35 | 2023 | Zephyr, Rain Sheath Transradial, Vista Brite Tip |
| Reflow Medical INC | $89.59 | 2024 | |
| Elutia, INC. | $73.07 | 2019 | |
| Recor Medical INC | $69.53 | 2025 | Paradise Ultrasound Renal Denervation System |
| Arbor Pharmaceuticals, INC. | $68.89 | 2019-2021 | |
| Daiichi Sankyo INC. | $68.67 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $67.86 | 2021 | |
| Medicomp INC | $54.41 | 2023-2024 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals, LTD. | $51.06 | 2021-2023 | Arcalyst |
| Bridgebio Pharma, INC. | $44.59 | 2025 | Attruby |
| Irhythm Technologies, INC. | $41.31 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Chiesi USA, INC. | $41.15 | 2025 | Juxtapid, Cleviprex, Kengreal |
| United Therapeutics Corporation | $39.17 | 2020-2023 | Tyvaso |
| Genzyme Corporation | $38.72 | 2019 | |
| Glaxosmithkline, LLC. | $37.68 | 2025 | Shingrix |
| Cleerly, INC. | $34.76 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Gilead Sciences, INC. | $31.47 | 2019 | |
| Preventice Services, LLC | $28.15 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.89 | 2020 | |
| Aegerion Pharmaceuticals, INC. | $23.37 | 2019 | |
| Cashflow Solutions, LLC | $21.55 | 2022 | |
| Cathworks, INC. | $20.92 | 2019 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Ethicon US, LLC | $19.79 | 2025 | Vistaseal, Stratafix |
| Heartflow, INC. | $19.63 | 2025 | |
| Baxter Healthcare | $18.68 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Siemens Medical Solutions USA, INC. | $12.74 | 2023 | Corpath Imaging System |
| Stryker Corporation | $12.72 | 2023 | Infinity Adaptis |
| Tactile Systems Technology INC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.